IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,598,835 | +69.5% | 477,553 | +87.2% | 0.00% | +200.0% |
| Q2 2023 | $2,713,934 | +18560.2% | 255,069 | -81.6% | 0.00% | -87.5% |
| Q1 2023 | $14,544 | -70.6% | 1,382,548 | -65.3% | 0.01% | -70.4% |
| Q4 2022 | $49,435 | -99.7% | 3,989,942 | +121.0% | 0.03% | +145.5% |
| Q3 2022 | $18,702,000 | +50.0% | 1,805,175 | +67.0% | 0.01% | +37.5% |
| Q2 2022 | $12,464,000 | -5.8% | 1,080,972 | +2.7% | 0.01% | +14.3% |
| Q1 2022 | $13,236,000 | -28.6% | 1,052,114 | -33.8% | 0.01% | -22.2% |
| Q4 2021 | $18,537,000 | -8.2% | 1,589,816 | +2.9% | 0.01% | -25.0% |
| Q3 2021 | $20,184,000 | -10.8% | 1,545,482 | -12.1% | 0.01% | -14.3% |
| Q2 2021 | $22,638,000 | +105.9% | 1,758,953 | +78.9% | 0.01% | +75.0% |
| Q1 2021 | $10,995,000 | +12.6% | 983,457 | +14.8% | 0.01% | +14.3% |
| Q4 2020 | $9,762,000 | +1286.6% | 857,035 | +994.7% | 0.01% | +600.0% |
| Q3 2020 | $704,000 | -78.0% | 78,286 | -74.8% | 0.00% | -75.0% |
| Q2 2020 | $3,202,000 | +1223.1% | 310,298 | +1194.0% | 0.00% | +300.0% |
| Q1 2020 | $242,000 | -97.3% | 23,980 | -96.4% | 0.00% | -90.9% |
| Q4 2019 | $8,903,000 | +0.6% | 668,917 | -35.1% | 0.01% | -21.4% |
| Q3 2019 | $8,853,000 | +112.1% | 1,031,298 | +170.4% | 0.01% | +133.3% |
| Q2 2019 | $4,173,000 | -64.5% | 381,467 | -56.1% | 0.01% | -66.7% |
| Q1 2019 | $11,745,000 | -17.4% | 868,058 | -36.8% | 0.02% | -18.2% |
| Q4 2018 | $14,225,000 | +194.9% | 1,373,080 | +425.5% | 0.02% | +266.7% |
| Q3 2018 | $4,823,000 | +274.7% | 261,266 | +288.2% | 0.01% | +200.0% |
| Q2 2018 | $1,287,000 | +250.7% | 67,305 | +175.1% | 0.00% | +100.0% |
| Q4 2017 | $367,000 | -41.6% | 24,465 | -26.4% | 0.00% | 0.0% |
| Q2 2017 | $628,000 | -73.4% | 33,260 | -76.0% | 0.00% | -75.0% |
| Q1 2017 | $2,363,000 | -41.5% | 138,502 | -47.6% | 0.00% | -50.0% |
| Q4 2016 | $4,038,000 | -36.8% | 264,105 | -34.4% | 0.01% | -27.3% |
| Q3 2016 | $6,389,000 | -24.9% | 402,321 | -38.1% | 0.01% | -42.1% |
| Q2 2016 | $8,505,000 | +548.2% | 650,472 | +442.2% | 0.02% | +533.3% |
| Q1 2016 | $1,312,000 | -61.3% | 119,971 | -59.0% | 0.00% | -57.1% |
| Q4 2015 | $3,390,000 | -73.5% | 292,512 | -76.2% | 0.01% | -72.0% |
| Q3 2015 | $12,798,000 | +7.1% | 1,228,245 | +23.9% | 0.02% | +8.7% |
| Q2 2015 | $11,954,000 | -68.6% | 991,195 | -58.3% | 0.02% | -67.6% |
| Q1 2015 | $38,069,000 | -6.8% | 2,379,282 | -10.8% | 0.07% | -18.4% |
| Q4 2014 | $40,867,000 | +127.4% | 2,667,575 | +92.3% | 0.09% | +89.1% |
| Q3 2014 | $17,972,000 | -65.2% | 1,387,228 | -58.8% | 0.05% | -67.8% |
| Q2 2014 | $51,628,000 | -21.1% | 3,367,745 | -36.6% | 0.14% | -24.7% |
| Q1 2014 | $65,400,000 | +617.7% | 5,308,406 | +576.3% | 0.19% | +555.2% |
| Q4 2013 | $9,113,000 | -55.4% | 784,885 | -54.5% | 0.03% | -56.1% |
| Q3 2013 | $20,429,000 | +109.3% | 1,725,468 | +75.5% | 0.07% | +120.0% |
| Q2 2013 | $9,762,000 | – | 983,131 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |